AG Mukosale Immunität

About / Biography

  • Professor Däbritz is a clinical scientist trained in General Pediatrics, Pediatric Gastroenterology and Clinical Nutrition and has a clinical and research interest in inflammatory bowel diseases (IBD).
  • Professor Däbritz is also Honorary Professor in the Centre for Immunobiology at the Blizard Institute, Barts Cancer Institute the Barts & The London School of Medicine & Dentistry, Queen Mary University of London (UK).
  • Further information can be found at ORCID.
  • Professor Däbritz is available for student supervision

Research Projects

  • The focus of our research is to discover underlying mechanisms and better therapeutic approaches in the broad area of chronic inflammation and mucosal healing as it relates to adult and pediatric patients with IBD.
  • A particular emphasis currently is to define novel ways in which the course of Crohn’s disease can be altered by specific modulation of the monocyte compartment and the innate immune response. 
  • A second focus area is determining the molecular basis for the role of myeloid-derived regulatory cells in mouse genetic and experimental models of colitis.
  • Clinical research endeavors involve patient-based approaches to develop new prognostic biomarkers in IBD.
  • We are also actively involved in ongoing multi-center investigator-initiated and industry-supported clinical trials of new therapeutics and quality improvement efforts.

Research Awards (selection)

Collaborations (selection)


  • Denson LA, Trapnell BC, Däbritz J. Methods and composition for determining relapse in inflammatory bowel disease. Patent PCT/US20140379272014

Publications - Selected Original Articles

  • Complete list of publications available at PubMed

Publications - Selected Review Articles

  • Complete list of publications available at PubMed